Renovaro BiosciencesRENB 
$0.53-2.96%24h
-2.96%24h
Global rank27151
Market cap$29.54M
Change 7d-23.69%
YTD Performance-83.33%
SP500 benchmarkUnderperform
P/E-0.74
P/S0
Revenue$0
Earnings-$39.68M
Dividend yield-
Main Sector
Healthcare
Renovaro Biosciences (RENB) Net Assets
RENB Net Assets in 2023: $46.50M
As of 1 Nov 2024, Renovaro Biosciences net assets is $46.50M, an decrease of -35.96% to 2022. Net assets are calculated as total assets minus total liabilities. This value represents the Renovaro Biosciences overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.
Renovaro Biosciences Net Assets History from 2019 to 2024
-
Value:-
RENB Net Assets History by year
| Year | Net assets | Change |
|---|---|---|
| 2023 | $46.50M | -35.96% |
| 2022 | $72.62M | -58.42% |
| 2021 | $174.66M | 5.05% |
| 2020 | $166.27M | -415.71% |
| 2019 | $-52.67M | - |
View the Top Net Assets Companies
